Kiniksa Pharmaceuticals
KNSA
#4646
Rank
HK$11.49 B
Marketcap
๐Ÿ‡ง๐Ÿ‡ฒ
Country
HK$158.28
Share price
-6.43%
Change (1 day)
11.94%
Change (1 year)

Earnings for Kiniksa Pharmaceuticals (KNSA)

Earnings in 2024 (TTM): -HK$0.29 Billion

According to Kiniksa Pharmaceuticals 's latest financial reports the company's current earnings are HK$0.42 Billion. a decrease over its 2023 earnings that were of -HK$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Kiniksa Pharmaceuticals from 2017 to 2024

Annual earnings

Year Earnings Change
2024 -HK$0.29 Billion117.1%
2023 -HK$0.13 Billion-251.02%
2022 HK$85.71 M-107.04%
2021 -HK$1.22 Billion0.2%
2020 -HK$1.22 Billion-4.69%
2019 -HK$1.28 Billion58.46%
2018 -HK$0.81 Billion59.46%
2017 -HK$0.51 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$1.12 Billion 295.26%๐Ÿ‡บ๐Ÿ‡ธ USA